Hims & Hers Health Newsroom

Hims & Hers Health Options Trading: A Deep Dive Into Market Sentiment

Benzinga48minutes ago

Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says

MT Newswires51minutes ago

Tesla, Crypto Miners, Hims & Hers Health: Trending Tickers

Yahoo FinanceDec 17 23:48

Institutional Investors in Hims & Hers Health, Inc. (NYSE:HIMS) See US$302m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.

Simply Wall StDec 17 20:28

Hims & Hers Health Initiated at Overweight by Morgan Stanley

Dow JonesDec 17 19:23 · Ratings

Hims & Hers Health Analyst Ratings

BenzingaDec 17 19:11 · Ratings

Morgan Stanley Initiates Hims & Hers Health(HIMS.US) With Buy Rating, Announces Target Price $42

Futu NewsDec 17 18:34 · Ratings

HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further?

Zacks Dec 16 19:35

Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)

TipRanksDec 16 14:30 · Ratings

"Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News

BenzingaDec 14 00:16

Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating

Futu NewsDec 13 20:31 · Ratings

Truist Financial Gives a Hold Rating to Hims & Hers Health (HIMS)

TipRanksDec 13 20:17 · Ratings

Hims & Hers Health Insider Sold Shares Worth $2,653,129, According to a Recent SEC Filing

MT NewswiresDec 13 06:12

Josh Brown Unveils The 'Degen Dow,' A Basket Of 30 Retail Darlings Spanning All 'Major Degen Food Groups'

BenzingaDec 13 03:29

Unusual Options Activity: CRDO, HIMS and Others Attract Market Bets, CRDO V/OI Ratio Reaches 105.2

EST Dec 12th Afternoon Delivery - In the last two hours of trading, 7 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu NewsDec 13 02:30

BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18

Futu NewsDec 12 19:31 · Ratings

Challenging Outlook for Hims & Hers Health Amid DTC Model Disruption and Profit Margin Concerns

TipRanksDec 12 18:55

'Eli Lilly to Sell Zepbound Through Telehealth Company Ro' - Barron's

BenzingaDec 12 00:25

Hims & Hers Health Unusual Options Activity

BenzingaDec 11 23:31

Hims & Hers Health, Inc. Falls 7% as Ro Says It Is Working With Eli Lilly to Streamline Access to Zepbound

InvestingDec 11 21:22